医学
化疗
内科学
肿瘤科
腺癌
胰腺导管腺癌
随机对照试验
吉西他滨
临床研究阶段
叶黄素
胰腺癌
化疗方案
外科
胃肠病学
癌症
作者
Pascal Hammel,Jean‐Philippe Metges,Teresa Macarulla,Rocio García‐Carbonero,Olivier Bouché,Fabienne Portales,Roberto Pazo-Cid,Laurent Mineur,Antonio Cubillo Gracián,Isabelle Trouilloud,Rosine Guimbaud,David Tougeron,Juan José Reina,Jaime Feliú,Tamara Saurí,Christos Fountzilas,Thierry Lecomte,Yann Molin,Mariano Ponz‐Sarvisé,Frédéric Forget
摘要
The addition of eryaspase to chemotherapy did not improve OS, PFS, or ORR. AEs were generally consistent with previous reports of chemotherapy. These results do not support additional development of eryaspase in PDAC.
科研通智能强力驱动
Strongly Powered by AbleSci AI